Log in to save to my catalogue

Tolcapone: A review of its use in the management of Parkinson's Disease

Tolcapone: A review of its use in the management of Parkinson's Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67413831

Tolcapone: A review of its use in the management of Parkinson's Disease

About this item

Full title

Tolcapone: A review of its use in the management of Parkinson's Disease

Publisher

Hong Kong: Adis International

Journal title

CNS drugs, 2005-01, Vol.19 (2), p.165-184

Language

English

Formats

Publication information

Publisher

Hong Kong: Adis International

More information

Scope and Contents

Contents

Tolcapone (Tasmar) is a selective, reversible inhibitor of peripheral and central catechol-O-methyltransferase (COMT). Results of well designed studies indicate that oral tolcapone is an effective adjunct to levodopa plus a peripheral dopa-decarboxylase inhibitor (DDCI) in patients with fluctuating Parkinson's disease. Tolcapone significantly impro...

Alternative Titles

Full title

Tolcapone: A review of its use in the management of Parkinson's Disease

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_67413831

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67413831

Other Identifiers

ISSN

1172-7047

DOI

10.2165/00023210-200519020-00006

How to access this item